Edmond DE Rothschild Holding S.A. cut its position in CVS Health Corporation (NYSE:CVS) by 86.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,588 shares of the pharmacy operator’s stock after selling 10,395 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in CVS Health Corporation were worth $125,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CVS. Mercer Capital Advisers Inc. purchased a new position in CVS Health Corporation during the first quarter valued at $118,000. Orrstown Financial Services Inc. increased its position in CVS Health Corporation by 2,000.0% in the first quarter. Orrstown Financial Services Inc. now owns 2,100 shares of the pharmacy operator’s stock valued at $165,000 after buying an additional 2,000 shares during the period. SRS Capital Advisors Inc. increased its position in CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares during the period. Edmp Inc. purchased a new position in CVS Health Corporation during the first quarter valued at $202,000. Finally, Pinnacle Bank purchased a new position in CVS Health Corporation during the first quarter valued at $203,000. Institutional investors and hedge funds own 81.92% of the company’s stock.

CVS Health Corporation (CVS) traded up 0.34% during mid-day trading on Friday, reaching $79.41. 2,985,502 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of $78.83 and a 200 day moving average price of $78.96. The company has a market cap of $80.73 billion, a PE ratio of 15.82 and a beta of 0.91. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $98.44.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.02. The business had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. CVS Health Corporation’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.32 EPS. Equities analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.00 annualized dividend and a dividend yield of 2.52%. CVS Health Corporation’s dividend payout ratio is currently 39.92%.

COPYRIGHT VIOLATION WARNING: “Edmond DE Rothschild Holding S.A. Reduces Stake in CVS Health Corporation (CVS)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.watchlistnews.com/edmond-de-rothschild-holding-s-a-reduces-stake-in-cvs-health-corporation-cvs/1478089.html.

Several research analysts have recently weighed in on CVS shares. Vetr raised shares of CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 target price on the stock in a research report on Wednesday, May 24th. Tigress Financial started coverage on shares of CVS Health Corporation in a research report on Thursday, April 27th. They issued a “buy” rating on the stock. Leerink Swann set a $90.00 target price on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, June 27th. Guggenheim reissued a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Finally, Needham & Company LLC started coverage on shares of CVS Health Corporation in a research report on Tuesday, June 27th. They issued a “hold” rating on the stock. Eight investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $91.27.

In other news, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction that occurred on Monday, June 19th. The shares were sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the completion of the transaction, the executive vice president now directly owns 59,300 shares of the company’s stock, valued at approximately $4,564,914. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the transaction, the chief financial officer now directly owns 176,983 shares of the company’s stock, valued at $14,158,640. The disclosure for this sale can be found here. Insiders have sold a total of 271,175 shares of company stock valued at $21,632,597 over the last ninety days. Company insiders own 0.61% of the company’s stock.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.